838 related articles for article (PubMed ID: 31319086)
1. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
3. Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function.
Hu J; Li P; Song Y; Ge YX; Meng XM; Huang C; Li J; Xu T
J Cell Physiol; 2018 Jun; 233(6):4408-4422. PubMed ID: 28833094
[TBL] [Abstract][Full Text] [Related]
4. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
6. CircRNA has_circ_0078710 acts as the sponge of microRNA-31 involved in hepatocellular carcinoma progression.
Xie B; Zhao Z; Liu Q; Wang X; Ma Z; Li H
Gene; 2019 Jan; 683():253-261. PubMed ID: 30342168
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
Zhang C; Zhang C; Lin J; Wang H
Cell Physiol Biochem; 2018; 51(1):290-300. PubMed ID: 30453307
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
Zhao J; Wang Y; Su H; Su L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.
Koduru SV; Leberfinger AN; Kawasawa YI; Mahajan M; Gusani NJ; Sanyal AJ; Ravnic DJ
Sci Rep; 2018 May; 8(1):7967. PubMed ID: 29789629
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs involved with hepatocellular carcinoma (Review).
Mao B; Wang G
Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
[TBL] [Abstract][Full Text] [Related]
20. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.
Shen S; Lin Y; Yuan X; Shen L; Chen J; Chen L; Qin L; Shen B
Sci Rep; 2016 Dec; 6():38311. PubMed ID: 27917899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
